Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Bipolar Disorders|June 17, 2011
The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy malesPanos Roussos, Stella G Giakoumaki, Anastasios Georgakopoulos, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 11, 2008
Wild-type but not FAD mutant presenilin-1 prevents neuronal degeneration by promoting phosphatidylinositol 3-kinase neuroprotective signalingLia Baki, Rachael L Neve, Zhiping Shao, et al.
The EMBO Journal|March 3, 2006
Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signalingAnastasios Georgakopoulos, Claudia Litterst, Enrico Ghersi, et al.
Journal of Neurochemistry|January 27, 2007
FAD mutants unable to increase neurotoxic Abeta 42 suggest that mutation effects on neurodegeneration may be independent of effects on AbetaJunichi Shioi, Anastasios Georgakopoulos, Pankaj Mehta, et al.
The Journal of Biological Chemistry|August 30, 2005
Cadherins mediate both the association between PS1 and beta-catenin and the effects of PS1 on beta-catenin stabilityGeo Serban, Zen Kouchi, Lia Baki, et al.
The Journal of Biological Chemistry|April 13, 2007
Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptorClaudia Litterst, Anastasios Georgakopoulos, Junichi Shioi, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
PS FAD mutants and γ-secretase inhibition accumulate VEGFR2-derived peptide VCTF1 suppressing brain VEGFR2 dimerization, angiogenesis and neuroprotectionRukmani Pandey, Amira Zarrouk, Poulomi Dey, et al.
Pflugers Archiv : European Journal of Physiology|November 26, 2010
Phosphatidylinositol-4,5-bisphosphate regulates epidermal growth factor receptor activationIoannis E Michailidis, Radda Rusinova, Anastasios Georgakopoulos, et al.
Advances in Experimental Medicine and Biology|May 30, 2020
What Do Recent Clinical Trials Teach Us About the Etiology of ADNikolaos K Robakis
Neurochemical Research|February 26, 2013
Cell signaling abnormalities may drive neurodegeneration in familial Alzheimer diseaseNikolaos K Robakis
Pageof 7